Formulation Of Liposomes As A Drug Carrier For Buparvaquone
Kajian ini merangkumi penyediaan liposom sebagai pembawa drug buparvaquone yang merupakan ubat bagi rawatan penyakit leishmaniasis. Kajian awal bertumpu untuk menggantikan penggunaan klorofom dengan etanol sebagai pelarut lipid. Keputusan yang diperoleh menunjukkan liposom boleh dilarutkan dalam eta...
Saved in:
Main Author: | Narianan, Shailaja |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://eprints.usm.my/31783/1/SHAILAJA_NARIANAN_24%28NN%29.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Investigation Of Liposomes For Oral Delivery Of A Poorly Bioavailable Model Drug: Griseofulvin
by: Ong , Sandy Gim Ming
Published: (2011) -
In Vitro And In Vivo Liposomes Formulation Studies Of Orthosiphon Stamineus Extract For Lung Cancer
by: Baharetha, Hussein Mahfoudh Saeed
Published: (2018) -
Evaluation of permeability and bioavailability of a lead antileishmanial compound buparvaquone in animal models [RS1-441].
by: Gantala Venkatesh, Gantala Venkatesh
Published: (2009) -
Solid Lipid Nanoparticles As Drug
Carriers For Atovaquone
by: Mohtar, Noratiqah
Published: (2013) -
Formulation Of Solid Self-Emulsifying
Drug Delivery System Using Mixedtocotrienols
As The Model Drug
by: Lee, You Zhuan
Published: (2020)